Ads
related to: therapeutic procedures for influenza virus protection in hospitals and healthcare
Search results
Results From The WOW.Com Content Network
Treatments for influenza include a range of medications and therapies that are used in response to disease influenza. Treatments may either directly target the influenza virus itself; or instead they may just offer relief to symptoms of the disease, while the body's own immune system works to recover from infection. [1]
However, researchers had suspected that there was more than one viral strain of influenza as some patients did not develop antibodies to the strain discovered in 1933. By undergoing many investigations, the researchers discovered the influenza B virus. Thus, the influenza B virus was added to the vaccines and packaged as a bivalent vaccine in 1942.
The influenza vaccine is indicated for active immunization for the prevention of influenza disease caused by influenza virus subtypes A and type B contained in the vaccine. [ 74 ] [ 75 ] [ 76 ] The US Centers for Disease Control and Prevention (CDC) recommends the flu vaccine as the best way to protect people against the flu and prevent its ...
In a hospital or sanitorium, this may be done by ensuring good ventilation in an airy, sunny room or by housing patients outdoors in tents or other open forms of accommodation. During the 20th century, such treatment was used for people with infectious respiratory diseases such as influenza or tuberculosis. [2]
It is an essential part of the infrastructure of health care. Infection control and hospital epidemiology are akin to public health practice, practiced within the confines of a particular health-care delivery system rather than directed at society as a whole. [citation needed]
[citation needed] In September 2009, a live attenuated influenza vaccine for the novel H1N1 influenza virus was approved [28] and the seasonal intranasal vaccine was approved by the European Medicines Agency (EMA) for use in the European Union in 2011. [5] The quadrivalent version was approved for use in the European Union in 2013. [6]
The following is a list of WHO recommended strains for the Northern Hemisphere influenza season. Starting in the 2012–2013 season, the recommendation shifted to include the composition of a quadrivalent influenza vaccine (QIV) that contains both influenza B lineages, alongside a trivalent influenza vaccine (TIV) containing one influenza B lineage.
Transmission-based precautions are infection-control precautions in health care, in addition to the so-called "standard precautions". They are the latest routine infection prevention and control practices applied for patients who are known or suspected to be infected or colonized with infectious agents, including certain epidemiologically important pathogens, which require additional control ...